Mendel Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Sell |
7,631
-34
| -0.4% | -$6.31K | 0.81% | 29 |
|
|
2025
Q1 | $1.61M | Buy |
7,665
+423
| +6% | +$88.6K | 0.97% | 22 |
|
|
2024
Q4 | $1.29M | Buy |
7,242
+29
| +0.4% | +$5.15K | 0.78% | 30 |
|
|
2024
Q3 | $1.42M | Buy |
7,213
+216
| +3% | +$42.7K | 0.87% | 29 |
|
|
2024
Q2 | $1.2M | Buy |
6,997
+71
| +1% | +$12.2K | 0.78% | 31 |
|
|
2024
Q1 | $1.26M | Buy |
6,926
+905
| +15% | +$165K | 0.83% | 27 |
|
|
2023
Q4 | $933K | Buy |
6,021
+254
| +4% | +$39.4K | 0.67% | 37 |
|
|
2023
Q3 | $860K | Buy |
5,767
+139
| +2% | +$20.7K | 0.71% | 35 |
|
|
2023
Q2 | $758K | Buy |
5,628
+81
| +1% | +$10.9K | 0.61% | 43 |
|
|
2023
Q1 | $884K | Buy |
5,547
+843
| +18% | +$134K | 0.8% | 31 |
|
|
2022
Q4 | $760K | Buy |
4,704
+224
| +5% | +$36.2K | 0.79% | 32 |
|
|
2022
Q3 | $601K | Buy |
4,480
+548
| +14% | +$73.5K | 0.71% | 33 |
|
|
2022
Q2 | $602K | Sell |
3,932
-191
| -5% | -$29.2K | 0.67% | 31 |
|
|
2022
Q1 | $668K | Buy |
4,123
+32
| +0.8% | +$5.19K | 0.63% | 32 |
|
|
2021
Q4 | $554K | Buy |
+4,091
| New | +$554K | 0.51% | 37 |
|